Santa Rosa, CA, United States of America

Gabriel Lazarus


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Bethesda, MD (US) (2020)
  • Santa Rosa, CA (US) (2021 - 2024)

Company Filing History:


Years Active: 2020-2024

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Gabriel Lazarus: Innovator in Renal Neuromodulation for Mental Health

Introduction

Gabriel Lazarus, a visionary inventor based in Santa Rosa, California, holds six patents that reflect his commitment to advancing medical technology. His work focuses primarily on the innovative methods of treating anxiety and eating disorders through renal neuromodulation.

Latest Patents

Lazarus's latest patents include groundbreaking methods for treating anxiety disorders in patients via renal neuromodulation. These methods aim to reduce the risk associated with developing anxiety disorders by modulating renal sympathetic nerve activity. Specifically, the patents detail how an intravascularly positioned catheter carries a therapeutic assembly designed to employ electrically-induced, thermally-induced, and chemically-induced techniques to enhance a patient's anxiety status.

Additionally, his patents encompass methods for treating eating disorders through similar renal neuromodulation techniques. By diminishing renal sympathetic nerve activity, these methods seek to improve patient outcomes both in terms of established eating disorder status and the likelihood of developing such disorders.

Career Highlights

Throughout his career, Gabriel Lazarus has demonstrated exceptional expertise and creativity in the medical device field. His work has led him to significant positions within renowned organizations, including Medtronic Ardian Luxembourg S.a.r.l. and Medtronic Ireland Manufacturing Unlimited Company, where he has contributed to innovative medical solutions that address critical health challenges.

Collaborations

Lazarus has collaborated with notable professionals in the industry, including Douglas A. Hettrick. Their joint efforts have further propelled advancements in renal neuromodulation techniques and solidified the impact of their collective innovations on patient care.

Conclusion

Gabriel Lazarus continues to be a leading figure in the invention of health technologies aimed at mitigating anxiety and eating disorders. His patented methods not only provide new avenues for treatment but also represent significant strides in understanding the intersection of renal function and mental health. As Lazarus advances his work, the potential for improved patient outcomes grows, promising hope for many suffering from these conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…